Chronos Archive seal
The Human Record

Jesse Owens

Case HR-ML042-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
September 12, 1913 – March 31, 1980
Synthetic DOB
1913-09-12
Index visit
1979-05-11 at age 65
Synthetic MRN
HR-ML042-SYN-TD

Teaching objective: Find lung cancer early in a 65-year-old Black man who has smoked a pack a day for 35 years and who was never offered screening: confirm eligibility on the USPSTF 1974 criteria (50 to 80 years, 20 pack-years or more, smoking now or quit within 15 years), hold the shared decision-making visit with a decision aid and tobacco treatment that the CMS coverage decision requires, read the low-dose CT with Lung-RADS, and work up a category 4X nodule without delay: PET-CT, brain MRI, systematic EBUS staging of the mediastinum (ACCP), and tissue for PD-L1 and comprehensive biomarker testing before any immunotherapy. Then treat resectable stage IIB adenocarcinoma on the NCCN guideline: tumor board review, physiologic evaluation for lobectomy (ACCP), three cycles of nivolumab with carboplatin and pemetrexed before surgery (CheckMate 816), immune-related adverse event monitoring, thoracoscopic lobectomy with lymph node dissection, and surveillance CT; treat tobacco dependence with varenicline even after the diagnosis; and track each step for delay, because Black Americans are less often found eligible for and offered screening and less often offered surgery for early lung cancer.

Historical timeline

DateEventClaims
September 12, 1913Born in Oakville, Alabama, to a sharecropping family.CLM-0001
about 1920Nearly dies of pneumonia at about 7, in an epidemic in which a brother and a sister die; the family soon moves to Cleveland.CLM-0002
1933National interscholastic records; enters the Ohio State University, where he is barred from the dormitory because of his race.CLM-0003, CLM-0004
August 1936Four gold medals at the Berlin Olympic Games.CLM-0005
1939Files for personal bankruptcy after a business fails; years of hardship and exclusion follow the Games.CLM-0006
1972Moves with his wife from Chicago to the Phoenix area.CLM-0007
1976Presidential Medal of Freedom; a pack-a-day smoker for decades.CLM-0008, CLM-0009
December 12, 1979Admitted in Chicago with shortness of breath; inoperable adenocarcinoma of the left lung diagnosed; chemotherapy in Chicago and Tucson.CLM-0010
March 31, 1980Dies of lung cancer in Tucson at 66.CLM-0011

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D James Cleveland (J.C.) Owens was born on September 12, 1913, in Oakville, Alabama, the youngest of the children of Henry and Mary Emma Owens, who were sharecroppers. The Ohio State University Libraries give ten children; contemporary newspaper accounts and his own account give nine.
The documented date used for the synthetic date of birth. The number of children differs between sources and is recorded as given.
confirmed Jesse Owens: A Lasting Legend. Growing Up supports
Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
HISTMED Master Roster v3 context
D As a child in Alabama he worked in the fields with his family. At about 7 he had pneumonia and nearly died; a brother and a sister died during the same epidemic. He later described himself as a sickly, emaciated, poverty-stricken child, and said that his parents knew the family had to leave to survive. In the early 1920s the family moved north to Cleveland, following an older sister who had written home about jobs there.
His own published account, repeated in contemporary newspaper obituaries, with the move dated by the Ohio State University Libraries. Anchors the past medical history (childhood pneumonia) and the family history.
probable Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
Jesse Owens: A Lasting Legend. Growing Up supports
D In Cleveland a teacher misheard his initials J.C. and called him Jesse, and the name stuck. Coached by Charles Riley from junior high school, he won the long jump, set a world record in the 220-yard dash and tied the world record in the 100-yard dash at the National Interscholastic Championship in 1933. confirmed Jesse Owens: A Lasting Legend. Growing Up supports
D At the Ohio State University, which he entered in 1933, he was barred from the men's dormitory because of his race, lived in a boarding house with other African American students, and could not eat in the restaurants along High Street. He worked as a freight elevator operator. At the Big Ten championships in May 1935 he set world records in the 220-yard dash, the 220-yard low hurdles and the long jump.
Documented racial discrimination in his education; it anchors the social history and the plan's attention to equity.
confirmed Jesse Owens: A Lasting Legend. Owens and The Ohio State University supports
Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
D At the 1936 Olympic Games in Berlin he won four gold medals, in the 100 meters, the 200 meters, the long jump and the 4 x 100-meter relay, and he was given a ticker-tape parade in New York on his return. confirmed Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
Jesse Owens: A Lasting Legend. Owens' Legacy: a National Icon supports
D The offers that followed the Games did not become steady work. He earned money racing against horses and local sprinters, and said that Black athletes were not allowed in any professional sport then. A dry-cleaning business he founded in 1938 went into debt, and he filed for personal bankruptcy in 1939. He owed taxes on his income after the Games, and decades later was in trouble with the Internal Revenue Service again for failing to file returns. He later worked through public relations firms, as a speaker, and with youth organizations.
Documented years of financial hardship and racial exclusion after the Games. Anchors the modern social history (speaking and youth work) and the plan's attention to cost and access.
confirmed Jesse Owens: A Lasting Legend. Owens' Legacy: a National Icon supports
Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
D He met Minnie Ruth Solomon at Fairmount Junior High School in Cleveland in 1930; they married and had three daughters. In the early 1970s, with their children grown, they moved from Chicago, their home of more than 20 years, to the Phoenix area of Arizona. Ruth Owens died in 2001.
Anchors the modern household. His daughters are not named and no relative is given a role or a health fact in the modern episode.
confirmed Jesse Owens: A Lasting Legend. The Owens Family supports
Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
D The Ohio State University awarded him an honorary doctorate of athletic arts, and in 1976 he received the Presidential Medal of Freedom. He served on the board of directors of the U.S. Olympic Committee from 1973. confirmed Jesse Owens: A Lasting Legend. Owens and The Ohio State University supports
Jesse Owens: A Lasting Legend. Owens' Legacy: a National Icon supports
Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
D He smoked cigarettes for decades: at his death newspapers described him as a pack-a-day smoker for the past 35 years, and his doctors said he had smoked about a pack a day. The Ohio State University Libraries call him a lifetime smoker.
About 35 pack-years, the figure used for the modern smoking history; it meets the 2021 USPSTF screening threshold of 20 pack-years. The start year is not documented.
probable Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
Jesse Owens: A Lasting Legend. The Owens Family supports
D He was admitted to Michael Reese Hospital in Chicago on December 12, 1979, after reporting shortness of breath; the illness was diagnosed as adenocarcinoma of the left lung, described as inoperable. He received chemotherapy, was moved when he was able to travel to University Hospital in Tucson, and had outpatient chemotherapy at the University of Arizona Cancer Center, with breathlessness and difficulty talking.
The documented diagnosis to which the synthetic modern adenocarcinoma of the left upper lobe is linked. In the modern episode the cancer is found by screening at an earlier stage, which is the teaching contrast.
confirmed Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
Jesse Owens: A Lasting Legend. The Owens Family supports
D He died of lung cancer on March 31, 1980, at 66, at the University of Arizona Health Sciences Center in Tucson, about three and a half months after he was first admitted, with his wife at his side.
History only, after the true-frame episode; stated without detail.
confirmed Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) supports
Jesse Owens: A Lasting Legend. The Owens Family supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Solid, spiculated 2.9 cm nodule in the left upper lobe with an enlarged (1.6 cm) left hilar lymph node on today's low-dose screening CT, Lung-RADS 4X (very suspicious); no symptoms of lung cancer. PET-CT, tissue diagnosis and thoracic oncology review booked resolved confirmed active CLM-0009
S Adenocarcinoma of the left upper lobe of the lung, cT1c N1 M0, stage IIB (AJCC 8th edition), resectable: 2.9 cm primary with a positive left interlobar (11L) node on EBUS; mediastinal nodes 4R, 4L and 7 negative; no metastases on PET-CT or brain MRI. PD-L1 tumor proportion score 40 percent (22C3); KRAS G12C mutation; no EGFR, ALK, ROS1, BRAF, MET exon 14, RET, NTRK or HER2 alteration active confirmed both_with_link CLM-0010, CLM-0011
S Nicotine dependence, cigarettes: a pack a day for 35 years (35 pack-years); smokes his first cigarette within 30 minutes of waking; two attempts to stop, each lasting a few weeks without medicine resolved confirmed both_with_link CLM-0009
S Acute viral upper respiratory infection (rhinovirus on a respiratory panel) on day 13 of cycle 2 of chemoimmunotherapy: runny nose, sore throat and a dry cough for three days, no hypoxia, clear chest X-ray; immune-related pneumonitis and pneumonia excluded; resolved resolved confirmed active
S After thoracoscopic left upper lobectomy with mediastinal and hilar lymph node dissection: ypT1a N0 (0 of 16 nodes), R0, major pathologic response (6 percent residual viable tumor) active confirmed active CLM-0010, CLM-0011
S Nicotine dependence, cigarettes, in early remission: no cigarettes since day 1 of cycle 1, about four months, on varenicline active confirmed both_with_link CLM-0009

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1979-05-11 Hemoglobin [Mass/volume] in Blood 15.1 g/dL
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1979-05-11 Leukocytes [#/volume] in Blood by Automated count 8.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1979-05-11 Platelets [#/volume] in Blood by Automated count 262 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1979-05-11 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1979-05-11 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1979-05-11 Creatinine [Mass/volume] in Serum or Plasma 1 mg/dL
Reference 0.7-1.3 mg/dL
http://loinc.org · 2160-0
S 1979-05-11 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 84 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1979-05-11 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1979-05-11 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1979-05-11 Albumin [Mass/volume] in Serum or Plasma 4.2 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1979-05-11 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1979-05-11 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1979-05-11 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 84 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 1979-05-11 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1979-05-11 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1979-05-26 Hemoglobin [Mass/volume] in Blood 14.9 g/dL
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1979-05-26 Leukocytes [#/volume] in Blood by Automated count 8.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1979-05-26 Neutrophils [#/volume] in Blood by Automated count 5.2 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1979-05-26 Platelets [#/volume] in Blood by Automated count 258 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1979-05-26 Creatinine [Mass/volume] in Serum or Plasma 1 mg/dL
Reference 0.7-1.3 mg/dL
http://loinc.org · 2160-0
S 1979-05-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 84 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1979-05-26 Glucose [Mass/volume] in Serum or Plasma 97 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1979-05-26 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1979-05-26 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1979-05-26 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1979-05-26 Thyrotropin [Units/volume] in Serum or Plasma 1.9 mIU/L
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 1979-05-26 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1.2 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 1979-05-26 Cortisol [Mass/volume] in Serum or Plasma 13.8 ug/dL
Reference Morning (8 a.m.) reference interval
http://loinc.org · 2143-6
S 1979-05-26 FEV1 2.71 L
Reference Lower limit of normal for his age and height (GLI 1965)
http://loinc.org · 20150-9
S 1979-05-26 FEV1 measured/predicted 86%
Reference >=80%
http://loinc.org · 20152-5
S 1979-05-26 FEV1/FVC 0.73
Reference Below 0.70 after bronchodilator indicates airflow obstruction
http://loinc.org · 19926-5
S 1979-05-26 Diffusion capacity.carbon monoxide 23.6 mL/min/mm[Hg]
Reference Lower limit of normal for his age and height; predicted 27.4
http://loinc.org · 19911-7
S 1979-05-26 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1979-05-26 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 http://loinc.org · 70274-6
S 1979-06-24 Hemoglobin [Mass/volume] in Blood 13.6 g/dL
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1979-06-24 Leukocytes [#/volume] in Blood by Automated count 6.9 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1979-06-24 Neutrophils [#/volume] in Blood by Automated count 4.1 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1979-06-24 Platelets [#/volume] in Blood by Automated count 214 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1979-06-24 Creatinine [Mass/volume] in Serum or Plasma 1 mg/dL
Reference 0.7-1.3 mg/dL
http://loinc.org · 2160-0
S 1979-06-24 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 84 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1979-06-24 Glucose [Mass/volume] in Serum or Plasma 101 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1979-06-24 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1979-06-24 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 25 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1979-06-24 Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1979-06-24 Thyrotropin [Units/volume] in Serum or Plasma 2.6 mIU/L
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 1979-06-24 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1.1 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 1979-06-24 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1979-08-05 Hemoglobin [Mass/volume] in Blood 12.8 g/dL (low)
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1979-08-05 Leukocytes [#/volume] in Blood by Automated count 6.2 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1979-08-05 Neutrophils [#/volume] in Blood by Automated count 3.6 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1979-08-05 Platelets [#/volume] in Blood by Automated count 188 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1979-08-05 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1979-08-05 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1979-08-05 Creatinine [Mass/volume] in Serum or Plasma 1.1 mg/dL
Reference 0.7-1.3 mg/dL
http://loinc.org · 2160-0
S 1979-08-05 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 74 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1979-08-05 Glucose [Mass/volume] in Serum or Plasma 95 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1979-08-05 Calcium [Mass/volume] in Serum or Plasma 9.3 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1979-08-05 Albumin [Mass/volume] in Serum or Plasma 4 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1979-08-05 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1979-08-05 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1979-08-05 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 90 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 1979-08-05 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1979-08-05 Thyrotropin [Units/volume] in Serum or Plasma 6.8 mIU/L (high)
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 1979-08-05 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 1979-08-05 Cortisol [Mass/volume] in Serum or Plasma 12.9 ug/dL
Reference Morning (8 a.m.) reference interval
http://loinc.org · 2143-6
S 1979-08-05 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1979-09-30 Hemoglobin [Mass/volume] in Blood 13.4 g/dL (low)
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1979-09-30 Leukocytes [#/volume] in Blood by Automated count 7 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1979-09-30 Neutrophils [#/volume] in Blood by Automated count 4.3 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1979-09-30 Platelets [#/volume] in Blood by Automated count 246 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1979-09-30 Creatinine [Mass/volume] in Serum or Plasma 1 mg/dL
Reference 0.7-1.3 mg/dL
http://loinc.org · 2160-0
S 1979-09-30 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 84 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1979-09-30 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1979-09-30 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1979-09-30 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1979-09-30 Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1979-09-30 Thyrotropin [Units/volume] in Serum or Plasma 4.6 mIU/L (high)
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 1979-09-30 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1.1 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 1979-09-30 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1979-07-06 Hemoglobin [Mass/volume] in Blood 13.1 g/dL (low)
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1979-07-06 Leukocytes [#/volume] in Blood by Automated count 5.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1979-07-06 Neutrophils [#/volume] in Blood by Automated count 3.2 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1979-07-06 Platelets [#/volume] in Blood by Automated count 176 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1979-10-21 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1979-10-21 Total score [Mini-Cog] 5 http://loinc.org · 72233-0
S 1979-10-21 Total score [AUDIT-C] 2 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
1979-05-11Body height178 cm8302-2S
1979-05-11Body weight77 kg29463-7S
1979-05-11Body mass index (BMI) [Ratio]24.3 kg/m239156-5S
1979-05-11Systolic blood pressure134 mm[Hg]8480-6S
1979-05-11Diastolic blood pressure82 mm[Hg]8462-4S
1979-05-11Heart rate78 /min8867-4S
1979-05-11Respiratory rate16 /min9279-1S
1979-05-11Body temperature36.7 Cel8310-5S
1979-05-11Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
1979-05-26Body height178 cm8302-2S
1979-05-26Body weight76.6 kg29463-7S
1979-05-26Body mass index (BMI) [Ratio]24.2 kg/m239156-5S
1979-05-26Systolic blood pressure130 mm[Hg]8480-6S
1979-05-26Diastolic blood pressure80 mm[Hg]8462-4S
1979-05-26Heart rate80 /min8867-4S
1979-05-26Respiratory rate16 /min9279-1S
1979-05-26Body temperature36.6 Cel8310-5S
1979-05-26Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
1979-06-24Body height178 cm8302-2S
1979-06-24Body weight75.8 kg29463-7S
1979-06-24Body mass index (BMI) [Ratio]23.9 kg/m239156-5S
1979-06-24Systolic blood pressure126 mm[Hg]8480-6S
1979-06-24Diastolic blood pressure78 mm[Hg]8462-4S
1979-06-24Heart rate74 /min8867-4S
1979-06-24Respiratory rate16 /min9279-1S
1979-06-24Body temperature36.6 Cel8310-5S
1979-06-24Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1979-08-05Body height178 cm8302-2S
1979-08-05Body weight75.2 kg29463-7S
1979-08-05Body mass index (BMI) [Ratio]23.7 kg/m239156-5S
1979-08-05Systolic blood pressure124 mm[Hg]8480-6S
1979-08-05Diastolic blood pressure76 mm[Hg]8462-4S
1979-08-05Heart rate72 /min8867-4S
1979-08-05Respiratory rate14 /min9279-1S
1979-08-05Body temperature36.5 Cel8310-5S
1979-08-05Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1979-09-30Body height178 cm8302-2S
1979-09-30Body weight74.6 kg29463-7S
1979-09-30Body mass index (BMI) [Ratio]23.5 kg/m239156-5S
1979-09-30Systolic blood pressure122 mm[Hg]8480-6S
1979-09-30Diastolic blood pressure76 mm[Hg]8462-4S
1979-09-30Heart rate76 /min8867-4S
1979-09-30Respiratory rate16 /min9279-1S
1979-09-30Body temperature36.6 Cel8310-5S
1979-09-30Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1979-07-06Body height178 cm8302-2S
1979-07-06Body weight75.6 kg29463-7S
1979-07-06Body mass index (BMI) [Ratio]23.9 kg/m239156-5S
1979-07-06Systolic blood pressure128 mm[Hg]8480-6S
1979-07-06Diastolic blood pressure78 mm[Hg]8462-4S
1979-07-06Heart rate84 /min8867-4S
1979-07-06Respiratory rate16 /min9279-1S
1979-07-06Body temperature37.6 Cel8310-5S
1979-07-06Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1979-10-21Body height178 cm8302-2S
1979-10-21Body weight75 kg29463-7S
1979-10-21Body mass index (BMI) [Ratio]23.7 kg/m239156-5S
1979-10-21Systolic blood pressure124 mm[Hg]8480-6S
1979-10-21Diastolic blood pressure76 mm[Hg]8462-4S
1979-10-21Heart rate70 /min8867-4S
1979-10-21Respiratory rate16 /min9279-1S
1979-10-21Body temperature36.6 Cel8310-5S
1979-10-21Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
PET-CT, brain MRI, EBUS staging, tissue diagnosis, PD-L1 and comprehensive biomarker results and a tumor board plan within three weeks of the screening CT1979-05-26completedPET-CT in three days, brain MRI in four, EBUS in eight, tumor board in ten; PD-L1 and tissue sequencing back by the consultation, 15 days after the scan
Stop smoking completely before treatment starts and stay stopped1979-09-30completedNo cigarettes since day 1 of cycle 1, about four months; varenicline continued to complete 24 weeks
Three cycles of chemoimmunotherapy before surgery without a delay of more than one week and without an immune-related adverse event of grade 2 or higher1979-08-05completedThree cycles on schedule; only a grade 1 rise in TSH, monitored without treatment
Complete resection (R0) with systematic lymph node dissection within six weeks of the last cycle1979-09-30completedThoracoscopic left upper lobectomy five weeks after cycle 3; R0; major pathologic response
Back to walking 3 km most mornings by three months after surgery1979-09-30completedWalking 2 km a day six weeks after surgery and starting pulmonary rehabilitation

Interventions

InterventionStatusGuideline
Referral to thoracic oncology: consultation within two weeks to review the screening CT, PET-CT and EBUS results with him and plan treatmentcompletedGL-NCCN-NSCLC-2026, GL-CMID-2026
Work-up of the Lung-RADS 4X nodule without delay: FDG PET-CT and brain MRI with contrast this week, then endobronchial ultrasound with systematic sampling of mediastinal and hilar nodes (at least stations 4R, 4L and 7, and any PET-avid node), with enough tissue for PD-L1 and comprehensive next-generation sequencing (EGFR, ALK, ROS1, BRAF, KRAS, MET exon 14, RET, NTRK, HER2) and plasma testing in parallel; nurse navigator to track each datecompletedGL-USPSTF-LUNG-2021, GL-ACCP-SCREEN-2021, GL-ACR-LUNGRADS-2022, GL-NCCN-NSCLC-2026, GL-ACCP-STAGING-2013
Tobacco treatment at every visit: brief advice, varenicline offered with a quit date, the Arizona quitline and counseling; stopping smoking improves outcomes even after a lung cancer diagnosiscompletedGL-USPSTF-TOB-2021, GL-CMID-2026
Equity safeguards: a nurse navigator, written results and next steps at each visit, transport and cost help offered, and time from scan to treatment tracked against the goalcompletedGL-ALDRICH-2019, GL-BACH-1999
Distress and depression screening at each visit, plain information he can share, and advance care planning when he is readycompletedGL-CMID-2026
Chemoimmunotherapy before surgery: nivolumab 360 mg with carboplatin (AUC 5) and pemetrexed 500 mg/m2 every three weeks for three cycles, with folic acid, vitamin B12 and dexamethasone premedication, hepatitis B, hepatitis C and HIV tests first, and restaging CT before surgerycompletedGL-NCCN-NSCLC-2026, GL-CHECKMATE816-2022
Immune-related adverse event monitoring: TSH, free T4, liver tests, creatinine, glucose and blood count before each cycle, morning cortisol at baseline and before surgery, and a written list of warning symptoms with a 24-hour oncology linecompletedGL-ASCO-IRAE-2021, GL-CMID-2026
Physiologic evaluation for lobectomy (spirometry and DLCO with predicted postoperative values) and prehabilitation: a pulmonary rehabilitation program during chemotherapycompletedGL-ACCP-PHYS-2013, GL-CMID-2026
Thoracoscopic left upper lobectomy with systematic mediastinal and hilar lymph node dissection after restaging shows response and no new diseasecompletedGL-NCCN-NSCLC-2026, GL-ACCP-EARLY-2013
After surgery: no further systemic therapy after a major pathologic response, by shared decision; history, examination and chest CT every six months for two to three years, then yearly low-dose CT; pulmonary rehabilitation after surgery; the KRAS G12C result kept on file for any recurrencecompletedGL-NCCN-NSCLC-2026, GL-ASCO-SURV-2020, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Jesse Owens: A Lasting Legend. Growing Up The Ohio State University Libraries biography
SRC-0002 Jesse Owens: A Lasting Legend. The Owens Family The Ohio State University Libraries biography
SRC-0003 Jesse Owens: A Lasting Legend. Owens and The Ohio State University The Ohio State University Libraries biography
SRC-0004 Jesse Owens: A Lasting Legend. Owens' Legacy: a National Icon The Ohio State University Libraries biography
SRC-0005 Owens, Jesse: biographical file 2 (newspaper clippings, including UPI, AP, the Columbus Dispatch, the Ohio State Lantern and his own published account) The Ohio State University Archives primary
SRC-0006 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check screening eligibility and the shared decision-making elements, the Lung-RADS 4X work-up, EBUS staging (cT1c N1, stage IIB), the choice of three cycles of nivolumab with carboplatin and pemetrexed before surgery and of no adjuvant therapy after a major pathologic response, the predicted postoperative lung function, the handling of the grade 1 TSH rise, the exclusion of pneumonitis at the sick visit, and varenicline started after the diagnosis.
provenance reviewnot_startedHe died in 1980; the recent-death rule does not apply. Claims rest on four Ohio State University Libraries exhibit pages and the Ohio State University Archives biographical clipping file. The smoking history, the documented adenocarcinoma of the left lung and the dates of admission and death are D; the screening, stage, biomarkers and treatment are synthetic. His daughters are not named.
safe messaging reviewnot_startedTobacco claims are marked sensitive. No mental health claim is made; mood screens are synthetic and below the threshold for a safety assessment. His death is recorded once, without detail. No relative is given a role in the modern episode; the president of the 1930s is not named.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.